天眼查App显示，近日，九尖蕲艾（深圳）科技有限公司成立，法定代表人为林镇鹏，注册资本10万人 民币，经营范围为一般经营项目是：生物化工产品技术研发；组织文化艺术交流活动；健康咨询服务 （不含诊疗服务）；养生保健服务（非医疗）；日用品批发；日用品销售；化妆品批发；化妆品零售； 品牌管理；电子产品销售；食品销售（仅销售预包装食品）；食品互联网销售（仅销售预包装食品）； 农副产品销售；食用农产品初加工；教育咨询服务（不含涉许可审批的教育培训活动）；招生辅助服 务；业务培训（不含教育培训、职业技能培训等需取得许可的培训）；技术服务、技术开发、技术咨 询、技术交流、技术转让、技术推广。（除依法须经批准的项目外，凭营业执照依法自主开展经营活 动），许可经营项目是：无。 ...

天眼查App显示，近日，南京溧臣生物科技有限公司成立，法定代表人为张义红，注册资本50万人民 币，经营范围为一般项目：生物化工产品技术研发；新材料技术研发；日用化学产品制造；专用化学产 品制造（不含危险化学品）；日用杂品制造；厨具卫具及日用杂品研发；日用品销售；日用百货销售； 日用化学产品销售；消毒剂销售（不含危险化学品）；传统香料制品经营；卫生用杀虫剂销售；卫生用 品和一次性使用医疗用品销售；个人卫生用品销售；普通货物仓储服务（不含危险化学品等需许可审批 的项目）；运输货物打包服务；装卸搬运；化妆品零售；专用化学产品销售（不含危险化学品）（除依 法须经批准的项目外，凭营业执照依法自主开展经营活动）。 ...

Core Viewpoint - The announcement indicates that Jiangsu Lanfeng Biochemical Co., Ltd., a subsidiary of Lanfeng Biochemical, will receive a capital increase of 30 million yuan from one of its original shareholders, Yuanjiang Bide Chemical Co., Ltd. [1] Group 1 - The capital increase consists of 3 million yuan added to registered capital and 27 million yuan added to capital reserves [1] - Other original shareholders of Lanfeng Biochemical plan to waive their preemptive rights to the capital increase [1] - After the capital increase, the registered capital of Lanfeng Biochemical will rise from 130 million yuan to 133 million yuan, and the company's ownership stake in Lanfeng Biochemical will decrease from 76.92% to 75.19% [1]

天眼查App显示，近日，宿迁迈睿琳生物科技有限公司成立，法定代表人为李浩，注册资本100万人民 币，经营范围为一般项目：生物化工产品技术研发；化妆品零售；日用百货销售；服装服饰零售；工艺 美术品及礼仪用品销售（象牙及其制品除外）；电子产品销售；日用化学产品销售；化妆品批发；个人 卫生用品销售；日用杂品销售；互联网销售（除销售需要许可的商品）（除依法须经批准的项目外，凭 营业执照依法自主开展经营活动）。 ...

天眼查App显示，近日，广东竞取生物科技有限公司成立，注册资本500万人民币，经营范围为一般项 目：生物化工产品技术研发；日用化学产品制造；技术服务、技术开发、技术咨询、技术交流、技术转 让、技术推广；化工产品生产（不含许可类化工产品）；化妆品批发；化工产品销售（不含许可类化工 产品）；品牌管理；专用化学产品制造（不含危险化学品）；专用化学产品销售（不含危险化学品）； 日用化工专用设备制造；日用化学产品销售；食品用洗涤剂销售；国内贸易代理；贸易经纪；网络技术 服务；信息技术咨询服务；日用百货销售；日用品销售；包装服务；家居用品制造；广告发布；广告制 作；广告设计、代理；卫生用品和一次性使用医疗用品销售；个人卫生用品销售；消毒剂销售（不含危 险化学品）；互联网销售（除销售需要许可的商品）；进出口代理；货物进出口；技术进出口。（除依 法须经批准的项目外，凭营业执照依法自主开展经营活动）许可项目：卫生用品和一次性使用医疗用品 生产；消毒剂生产（不含危险化学品）。（依法须经批准的项目，经相关部门批准后方可开展经营活 动，具体经营项目以相关部门批准文件或许可证件为准）。 ...

天眼查App显示，近日，广东尚得生物科技有限公司成立，注册资本500万人民币，经营范围为许可项 目：食品生产；食品销售；饲料生产；食品添加剂生产；饲料添加剂生产；食品互联网销售。（依法须 经批准的项目，经相关部门批准后方可开展经营活动，具体经营项目以相关部门批准文件或许可证件为 准）一般项目：生物化工产品技术研发；技术服务、技术开发、技术咨询、技术交流、技术转让、技术 推广；生物饲料研发；饲料原料销售；饲料添加剂销售；食品添加剂销售；宠物食品及用品批发；宠物 食品及用品零售；农副产品销售；食品销售（仅销售预包装食品）；保健食品（预包装）销售；工业用 动物油脂化学品制造；工业用动物油脂化学品销售；非食用植物油加工；非食用植物油销售；包装材料 及制品销售；初级农产品收购；智能仓储装备销售；普通货物仓储服务（不含危险化学品等需许可审批 的项目）；采购代理服务；销售代理；食品互联网销售（仅销售预包装食品）；互联网销售（除销售需 要许可的商品）；再生资源销售；再生资源回收（除生产性废旧金属）；资源再生利用技术研发。（除 依法须经批准的项目外，凭营业执照依法自主开展经营活动）。 ...

近期郑州将连续举办3场招聘会，覆盖多区域、多行业、多人群，累计提供超过2万个岗位。从零工 市场到重点企业专场，从传统行业到新兴业态，系列活动通过"岗位对接+技能培训+特色赋能"的创新 模式，为高校毕业生、待业青年等群体搭建多层次、立体化的就业服务平台。 为进一步丰富招聘会服务内涵，提升活动吸引力与实效性，主办方在招聘会期间同步策划了两大特 色活动。其中，短剧演员海选活动将为具有表演天赋、热爱文艺的求职者提供展示自我的舞台，优秀参 与者有望获得参与本土短剧拍摄的机会，为就业增添新路径；手工钩织培训则邀请专业讲师现场授课， 通过实操教学帮助求职者掌握手工钩织技能，拓宽灵活就业渠道，助力实现"一技在手，就业无忧"。 为提升求职体验，活动现场将设立企业招聘区、企业展示区，并开通手机端扫码投递简历等便捷服 务，为求职青年提供多元化的岗位匹配和面对面推荐机会。 12月10日上午，由郑州市就业创业服务中心、河南省零工市场联合主办的"攻坚促就业 奋进创未 来"2025年高校毕业生等青年就业服务攻坚行动暨河南省零工市场招聘会将在河南省零工市场二楼（经 北二路50号）举行。这场招聘会将为求职者提供8700多个岗位。 12月13日 ...

天眼查App显示，近日，宿州科蔺生物科技有限公司成立，法定代表人为李琼，注册资本30万人民币， 经营范围为许可项目：卫生用品和一次性使用医疗用品生产；食品用洗涤剂生产；建筑劳务分包（依法 须经批准的项目，经相关部门批准后方可开展经营活动，具体经营项目以相关部门批准文件或许可证件 为准）一般项目：生物化工产品技术研发；技术服务、技术开发、技术咨询、技术交流、技术转让、技 术推广；化工产品生产（不含许可类化工产品）；基础化学原料制造（不含危险化学品等许可类化学品 的制造）；专用化学产品制造（不含危险化学品）；日用化学产品制造；化工产品销售（不含许可类化 工产品）；食品用洗涤剂销售；个人卫生用品销售；日用品销售；专用化学产品销售（不含危险化学 品）；日用化学产品销售；日用百货销售；日用杂品制造；日用杂品销售；消毒剂销售（不含危险化学 品）；专业保洁、清洗、消毒服务；美发饰品销售；卫生用品和一次性使用医疗用品销售；化妆品零 售；办公用品销售（除许可业务外，可自主依法经营法律法规非禁止或限制的项目）。 ...

Core Insights - The European Commission has officially released a new bioeconomy strategy framework, focusing on "competitiveness + sustainability" as dual core objectives aimed at accelerating the circular economy and decarbonization while reducing dependence on imported fossil fuels [1] - The strategy identifies ten core application areas for bio-based materials and technologies, covering end products such as plastics, textiles, and chemicals, as well as key technological directions like biorefining, advanced fermentation, and permanent storage of biochar [1] - The bioeconomy is seen as a crucial pathway for Europe to enhance economic resilience and replace fossil-based products, supporting 17.1 million jobs and positioning Europe to capture a leading role in the global clean industry [1] Industry Developments - The bioeconomy in the EU has reached a scale of €2.7 trillion in 2023, with expanding application scenarios including bio-based chemicals from algae serving the pharmaceutical and daily chemical sectors, and bio-based plastics gradually replacing traditional materials in packaging and automotive parts [1] - The strategy aims to achieve three goals: enhancing resilience, increasing competitiveness, and protecting the ecosystem, with a commitment to ensuring that natural ecology remains the foundation of economic development [1] Implementation Framework - To unlock potential, the EU has established a three-dimensional implementation system of "regulation + funding + market": simplifying regulatory frameworks to incentivize sustainable business models while ensuring safety, guiding EU finances towards bio-based technologies, and setting demand targets through legislation [2] - The establishment of the "European Bio-based Alliance" aims to facilitate collective procurement of €10 billion in bio-based solutions by 2030 [2] - Industry responses have been positive, with calls for a specialized legal framework and market premium mechanisms for low-carbon products, emphasizing the need for stronger policy guidance to accelerate the commercialization of innovative results [2]

Core Viewpoint - The announcement details the completion of the 2025 restricted stock incentive plan by Jiangsu Lanfeng Biological Chemical Co., Ltd, including the number of shares granted, the recipients, and the conditions for vesting and performance assessment [1][19]. Group 1: Stock Grant Details - The number of restricted shares granted is 20.03 million, accounting for 5.63% of the company's total shares before the grant [1][7]. - The grant date for the restricted shares is November 24, 2025, with the shares set to be listed on December 8, 2025 [6][16]. - The grant price for the restricted shares is set at 2.64 yuan per share [7]. Group 2: Recipients and Approval Process - A total of 71 individuals are designated as recipients of the restricted shares, including senior management, middle management, and key employees [2][7]. - The decision-making process involved multiple board meetings and approvals, with legal opinions provided by Beijing Wanshang Tianqin Law Firm [3][5]. Group 3: Vesting Conditions - The vesting period for the restricted shares is set at 12 months and 24 months from the date of grant, during which the shares cannot be transferred or used as collateral [8][9]. - Performance assessment for the vesting of shares will be based on company-level and individual-level criteria over the years 2025 and 2026 [10][12]. Group 4: Financial Impact - The total number of shares after the grant will increase from 355.56 million to 375.59 million, affecting the shareholding structure of major shareholders [17][19]. - The incentive plan is expected to raise approximately 52.88 million yuan, which will be used to supplement working capital [15][17]. Group 5: Compliance and Reporting - The company has confirmed that there were no stock trading activities by participating directors and senior management in the six months prior to the grant [18]. - The company will continue to monitor shareholder equity changes and comply with relevant disclosure obligations [19].